InfuSystem Holdings Inc. (INFU) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for InfuSystem Holdings Inc. (INFU:NYSE), powered by AI.

Current Price
$8.80
P/E Ratio
27.4
Market Cap
182M
Sector
Healthcare
What is the InfuSystem Holdings Inc. stock price forecast?

InfuSystem Holdings Inc. is currently trading at $8.80. View real-time AI analysis on Alpha Lenz.

What is InfuSystem Holdings Inc. insider trading activity?

View the latest insider trading data for InfuSystem Holdings Inc. on Alpha Lenz.

What is InfuSystem Holdings Inc.'s P/E ratio?

InfuSystem Holdings Inc.'s P/E ratio is 27.4.

InfuSystem Holdings Inc.

NYSE · INFU
$8.80+0.00(+0.00%)Pre-marketNYSE regular session 09:30–16:00 ET
Ask about InfuSystem Holdings Inc.'s future dividend policy...
Alpha Chat Insight

InfuSystem Holdings Inc. trades at a P/E of 27.4 (premium valuation) with solid ROE of 11.5%.

Ask for details

Company Overview

InfuSystem Holdings Inc. is a leading provider of healthcare services specializing in the supply of durable medical equipment and third-party billing services across the United States and Canada. The company's primary function is to deliver innovative solutions for patients requiring ambulatory infusion pumps for chemotherapy, pain management, and other infusion therapies. Notably, InfuSystem Holdings Inc. supports oncologists and other healthcare stakeholders in managing complex, cost-critical medical treatments outside traditional hospital settings, enhancing patient care and operational efficiencies. It also impacts sectors such as oncology, surgery centers, and home healthcare by offering reliable equipment logistics and comprehensive documentation services. In the financial market, InfuSystem Holdings Inc. represents a critical intersection of healthcare delivery and medical technology, positioning itself as a key player in facilitating advanced medical care with an emphasis on patient comfort and accessibility.

CEOMs. Carrie A. Lachance B.S.N., M.B.A., R.N.
SectorHealthcare
IndustryMedical Instruments & Supplies
Employees502

Company Statistics

FY 2025

Profile

$181.79MMarket Cap
$143.44MRevenue
0.00Shares Out
502Employees

Margins

55.98%Gross
17.58%EBITDA
8.31%Operating
7.41%Pre-Tax
4.62%Net

Valuation

27.43P/E
3.17P/B
1.27EV/Sales
8.00EV/EBITDA
11.56P/FCF

Growth (CAGR)

9.28%Rev 3Yr
8.05%Rev 5Yr
93.16%Op Inc 3Yr
6.19%Op Inc 5Yr
616.72%Net Inc 3Yr
-17.49%Net Inc 5Yr

Returns

6.49%ROA
11.54%ROE
11.68%ROIC

Financial Health

$3.19MCash & Cash Equivalents
$40.05MNet Debt
75.42%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

InfuSystem Holdings Inc. (ticker: INFU) is a company listed on NYSE in the Healthcare sector (Medical Instruments & Supplies). It has approximately 502 employees. Market cap is $182M.

The current price is $8.8 with a P/E ratio of 27.43x and P/B of 3.17x.

ROE is 11.54% and operating margin is 8.31%. Annual revenue is $143M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
InfuSystem Holdings Inc. (INFU) Stock Forecast 2026 $8.80 — Price, Financials & Analyst Targets | Alpha Lenz